| Analysis of the impact of the Uruguay Round Agreements Act on pharmaceutical patents. | |
| | |
MedLine Citation:
|
PMID: 19998745 Owner: HSR Status: MEDLINE |
Abstract/OtherAbstract:
|
The Uruguay Round Agreements Act (URAA) was enacted by the United States Congress in 1994. The URAA provided substantial modifications to the framework for U.S. patent law that came into effect January 1, 1953. Changes in patent regulation are especially important in the pharmaceutical sector because the patent system determines, in large part, the reward that an inventor can derive from discovery of a new drug. Most pharmaceutical patents are classified as utility patents. Pharmaceutical patents may include claims for the active ingredient per se, for the formulation of the active ingredient for use as a pharmaceutical, for therapeutic indications and uses, and for methods of manufacturing the drug. The U.S. has a First-to-Invent system to establishing the right of priority of an invention, but most countries have a First-to-File priority system. The First-to-Invent system allows for public disclosure of inventions prior to patent filing. In contrast, the First-to-File system encourages early filing of patent applications. In both systems, filing an application for a patent as soon as the drug is discovered allows inventors to obtain an earlier date of invention relative to potential competitors and establish the right of priority over the invention. |
| | |
Authors:
|
Enrique Seoane-Vazquez; Rosa Rodriguez-Monguio; Sheryl L Szeinbach; Andrew Beyer; Jay Visaria |
Related Documents
:
|
16770065 - Kinetic spectrophotometric determination of traces of molybdenum(vi) by its inhibitory ... 18968515 - Catalytic spectrophotometric determination of tungsten using the malachite green-ti(iii... 18965675 - Flow injection method for the assay of the anti-arrhythmic procainamide hcl in drug for... 22920415 - Combining peak- and chromatogram-based retention time alignment algorithms for multiple... 16770065 - Kinetic spectrophotometric determination of traces of molybdenum(vi) by its inhibitory ... 17165125 - Design and testing of a disposable microfluidic chemiluminescent immunoassay for diseas... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Food and drug law journal Volume: 64 ISSN: 1064-590X ISO Abbreviation: Food Drug Law J Publication Date: 2009 |
Date Detail:
|
Created Date: 2009-12-10 Completed Date: 2009-12-22 Revised Date: 2010-01-13 |
Medline Journal Info:
|
Nlm Unique ID: 9215384 Medline TA: Food Drug Law J Country: United States |
Other Details:
|
Languages: eng Pagination: 171-81 Citation Subset: T |
Affiliation:
|
Ohio State University Colleges of Pharmacy and Public Health, Columbus, Ohio, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Drug Approval
/
legislation & jurisprudence* Humans Legislation, Drug* Patents as Topic / legislation & jurisprudence* Pharmaceutical Preparations Time Factors United States |
| Chemical | |
Reg. No./Substance:
|
0/Pharmaceutical Preparations |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's...
Next Document: FDA's proposed regulations to expand access to investigational drugs for treatment use: the status q...